AD-2132 / Yuhan Corp - LARVOL DELTA

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132 (clinicaltrials.gov) - P1; N=40; Completed; Sponsor: Addpharma Inc.; Active, not recruiting ➔ Completed

Trial completion

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132 (clinicaltrials.gov) - P1; N=40; Active, not recruiting; Sponsor: Addpharma Inc.; Not yet recruiting ➔ Active, not recruiting

Clinical • Enrollment closed